Story
Telix Pharmaceuticals Shares Climb on Strong Q2 Revenue and Upgraded Outlook
Shares of Telix Pharmaceuticals (ASX:TLX) rose 1.7% to A$15.35 on Tuesday, outperforming the broader Australian market after the company announced strong second-quarter results and an upgraded financial outlook for the year.
The stock's advance came as the benchmark ASX 200 index fell 0.6%, according to the report.
Strong Quarterly Performance
Telix reported a robust financial performance for the June quarter, driven by significant growth in its core business. The company highlighted the following figures in its update:
- Total quarterly revenue: A$247 million, an increase of 7% quarter-over-quarter and 21% year-over-year.
- Precision Medicine revenue: US$202 million, marking a 30% increase compared to the same period in the prior year.
Upgraded Full-Year Guidance
AdBuoyed by the strong results, Telix management raised its forecast for the full 2026 fiscal year. The company now expects total revenue and other income to exceed US$1 billion, tracking toward the upper end of its previous guidance of US$950–$970 million plus US$40 million in non-refundable income from Regeneron.
Telix also updated its research and development expenditure guidance to US$230–$270 million for the year. The company attributed the change to accelerated investment in high-value clinical programs, including its TLX597-Tx program and label expansion for Pixclara.
Clinical Trial Milestone
The positive financial update followed a key clinical development announced a day earlier. Telix confirmed that the first patient was dosed in its LUTEON Phase 3 trial for TLX250-Tx, a therapy for relapsed or recurrent clear cell renal cell carcinoma.
The trial marks a significant step, being the first-ever Phase 3 study of a carbonic anhydrase IX-targeted radiopharmaceutical therapy, according to the company's announcement.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.